Source Count: 14 | Weighted Score: 39 | Source Confidence: [4/5] | Primary Tier: 1 | Last Updated: March 11, 2026
Keywords: natural selection, disease adaptation, malaria, sickle cell, G6PD, Duffy antigen, plague, Black Death, CCR5-delta32, tuberculosis, HLA, pathogen-driven selection, balancing selection, heterozygote advantage, resistance allele
Category Tags: genetics, natural-selection, disease-adaptation, malaria, plague, pathogen, HLA
Cross-References: L_3_09 — HLA Diversity · Z_4_13 — Infectious Disease Biology · X_1_01 — Epidemics and History · L_4_13 — Ancient DNA Methods
QUICK SUMMARY
Infectious disease has been the most powerful selective force on the human genome throughout history. Pathogens — particularly malaria, plague, tuberculosis, smallpox, and cholera — have killed more humans than all other causes combined, and the relentless evolutionary arms race between human hosts and microbial parasites has left deep signatures across the genome. The most dramatic example is the cluster of genetic defenses against malaria (Plasmodium falciparum): the sickle cell trait (heterozygous HbS — providing ~90% protection against severe malaria through polymerization of deoxygenated hemoglobin that kills parasitized red blood cells), glucose-6-phosphate dehydrogenase (G6PD) deficiency (protective through oxidative stress in infected cells — the most common enzyme deficiency in the world, affecting ~400 million people), Duffy-negative blood group (homozygous DARC mutation eliminating the P. vivax receptor on red blood cells — nearly universal in sub-Saharan Africa, providing complete resistance to P. vivax), thalassemia (alpha and beta — reduced hemoglobin production that confers malaria resistance in heterozygotes), and hemoglobin C and E variants. These defenses all exhibit balancing selection — heterozygotes are protected against malaria while homozygotes suffer disease (sickle cell disease, severe G6PD deficiency, thalassemia major) — illustrating the evolutionary trade-off between infection resistance and genetic disease. The 2011 and 2014 ancient DNA studies of Black Death (Yersinia pestis, 1346-1353) victims by Bos, Krause, and colleagues demonstrated that the medieval plague bacterium was genomically nearly identical to modern strains — suggesting that the ~30-60% mortality of the Black Death was driven by immunological naivety rather than a uniquely virulent pathogen. Klunk et al. (2022) analyzed aDNA from pre- and post-plague London and found that the plague exerted strong selection on immune genes — including genes near ERAP2 (which processes peptides for HLA-I presentation), with protective alleles increasing in frequency by ~10% in a single generation. The CCR5-Δ32 deletion (which eliminates the CCR5 co-receptor used by HIV to enter cells) was long thought to have been selected by plague or smallpox — but its pre-plague frequency in aDNA suggests a more complex selection history. Across the genome, HLA diversity — the extraordinary polymorphism of the major histocompatibility complex — is maintained by pathogen-driven balancing selection: populations in regions with greater pathogen diversity carry greater HLA diversity, and specific HLA alleles are associated with resistance or susceptibility to particular infections.
1. VERIFIED CLAIMS (Tier 1 — Peer-Reviewed / Established)
1.1 Malaria as Selective Agent
- Plasmodium falciparum malaria has been the strongest selective force on the human genome in the last 10,000 years:
- Sickle cell (HbS): a single nucleotide change (Glu→Val at position 6 of the beta-globin gene) that causes HbS polymerization under low oxygen — heterozygotes (HbAS) have ~90% protection against severe malaria; homozygotes (HbSS) develop sickle cell disease. Frequency reaches ~20% in malaria-endemic West Africa — the classic example of heterozygote advantage (balanced polymorphism)
- G6PD deficiency: X-linked enzyme deficiency affecting ~400 million people — multiple independent mutations arising in Africa, the Mediterranean, and Asia. Protective mechanism: oxidative stress in G6PD-deficient red blood cells inhibits parasite growth
- Duffy-negative (FYO/FYO): homozygous null mutation in the Duffy Antigen Receptor for Chemokines (DARC) — eliminates the receptor used by P. vivax to enter red blood cells. Nearly 100% frequency in sub-Saharan Africa — one of the strongest selective sweeps in the human genome
- Thalassemias: alpha-thalassemia (deletion of HBA1/HBA2 genes) and beta-thalassemia (reduced HBB expression) — both provide malaria protection in heterozygous state. High frequency in Mediterranean, Middle Eastern, Southeast Asian populations
1.2 HLA Diversity and Pathogens
- The human leukocyte antigen (HLA) system (MHC in genetics) is the most polymorphic gene region in the human genome — HLA-A, -B, -C (class I) and HLA-DR, -DQ, -DP (class II) each have hundreds to thousands of alleles:
- Pathogen-driven balancing selection: Prugnolle et al. (2005) showed that HLA class I diversity across populations correlates with local pathogen richness — populations facing more diverse pathogens maintain more diverse HLA alleles
- Specific HLA alleles are associated with resistance to specific pathogens: HLA-B53 → malaria resistance in West Africa; HLA-B27 → slow HIV progression; HLA-DRB1 → tuberculosis resistance/susceptibility
1.3 Black Death Ancient DNA
- Bos et al. (2011): reconstructed the complete genome of Yersinia pestis from dental remains of Black Death victims (East Smithfield plague cemetery, London, 1348-1350):
- The medieval plague genome was nearly identical to modern Y. pestis strains — confirming Y. pestis caused the Black Death
- The extreme mortality (~30-60% of Europe in 5 years) was likely due to immunological naivety of the population, not uniquely enhanced virulence
2. CREDIBLE CLAIMS (Tier 2 — Academic / Debated but Supported)
2.1 Plague-Driven Selection on Immune Genes
- Klunk et al. (2022, Nature): aDNA analysis of 206 individuals from London and Denmark (pre-plague, plague-era, and post-plague):
- Identified 4 loci under strong selection during the Black Death — the strongest signal near ERAP2 (endoplasmic reticulum aminopeptidase 2), which trims peptides for HLA class I presentation
- The protective ERAP2 allele increased ~10% in frequency in a single generation — one of the strongest selection events ever directly measured in humans
- Other selected loci included genes involved in cytokine signaling and immune regulation
2.2 CCR5-Δ32 Selection History
- CCR5-Δ32: a 32-base-pair deletion in the CCR5 chemokine receptor gene — homozygotes are highly resistant to HIV-1 (R5-tropic strains)
- The deletion reaches ~10% frequency in Northern Europeans and is virtually absent outside Europe
- Originally proposed to have been selected by plague or smallpox — but aDNA studies (Hummel et al., 2005; Sabeti et al., various) have shown it was already present in Europe before the Black Death at moderate frequency
- Current view: the selection history of CCR5-Δ32 is complex and may involve multiple pathogens, or the allele may have risen partly by drift in small European populations
2.3 Tuberculosis and Natural Selection
- Mycobacterium tuberculosis has co-evolved with humans for ~70,000 years (Comas et al., 2013):
- TB exerted selection on immune genes including SLC11A1 (NRAMP1 — phagosomal iron transporter), TLR genes (innate immune receptors), and IFNG (interferon-gamma)
- The extreme historical mortality of TB in European cities ("White Plague") likely selected for resistance alleles — contributing to the observation that European-descended populations have somewhat lower TB susceptibility than populations without historical TB exposure
3. SPECULATIVE CLAIMS (Tier 3 — Possible but Unverified)
3.1 Autoimmune Disease as a Cost of Pathogen Resistance
- Many alleles that protect against infection are associated with increased risk of autoimmune disease: HLA alleles linked to pathogen resistance also confer risk for type 1 diabetes, rheumatoid arthritis, and celiac disease
- The "hygiene hypothesis" extends this: in pathogen-reduced environments, the immune system (shaped by millennia of pathogen-driven selection) may "overshoot," attacking self-tissues — contributing to the rise of autoimmune diseases in developed countries
3.2 Smallpox as a Major Selective Agent
- Smallpox (eliminated in 1979 by vaccination) likely exerted powerful selection for >3,000 years — but the specific genetic resistance mechanisms are poorly characterized because the disease no longer exists in human populations for study
4. DUBIOUS CLAIMS (Tier 4 — No Credible Source / Contradicted by Evidence)
4.1 CCR5-Δ32 Was Selected by the Black Death
- [OVERSIMPLIFIED] While plague-driven selection was initially an attractive hypothesis, aDNA data show the allele predates the Black Death — the selection history appears more complex than any single-pathogen explanation
4.2 Genetic Immunity Makes Vaccines Unnecessary
- [DANGEROUS MISINFORMATION] Even populations with partial genetic resistance to specific diseases benefit enormously from vaccination — genetic resistance is never complete, and herd immunity protects vulnerable individuals
COUNTER-ARGUMENTS
No significant counter-arguments exist in the scholarly literature for the core claims in this document. The genetic adaptation to infectious disease (malaria, plague, tuberculosis) represents established scientific consensus with no active scholarly dispute over the fundamental claims presented here.
IMAGES
| # | Description | Filename | Source | License |
|---|
No images assigned yet.
BIBLIOGRAPHY
- Allison, A.C | 1954 | "Protection Afforded by Sickle-Cell Trait against Subtertian Malarial Infection" | British Medical Journal | ∅ | 1.4857::290–294 | ∅ | ∅ | doi:10.1136/bmj.1.4857.290 | ∅ | ∅ | ∅
- Kwiatkowski, Dominic P | 2005 | "How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria" | American Journal of Human Genetics | ∅ | 77.2::171–192 | ∅ | ∅ | doi:10.1086/432519 | ∅ | ∅ | ∅
- Prugnolle, Franck, et al | 2005 | "Pathogen-Driven Selection and Worldwide HLA Class I Diversity" | Current Biology | ∅ | 15.11::1022–1027 | ∅ | ∅ | doi:10.1016/j.cub.2005.04.050 | ∅ | ∅ | ∅
- Bos, Kirsten I., et al | 2011 | "A Draft Genome of Yersinia pestis from Victims of the Black Death" | Nature | ∅ | 478.7370::506–510 | ∅ | ∅ | doi:10.1038/nature10549 | ∅ | ∅ | ∅
- Klunk, Jennifer, et al | 2022 | "Evolution of Immune Genes Is Associated with the Black Death" | Nature | ∅ | 611.7935::312–319 | ∅ | ∅ | doi:10.1038/s41586-022-05349-x | ∅ | ∅ | ∅
- Miller, Louis H., Susan J | 1976 | "The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype, FyFy" | New England Journal of Medicine | ∅ | 295.6::302–304 | Mason, David F | ∅ | ∅ | ∅ | ∅ | Clyde, and McGehee H; McGinniss
- Fumagalli, Matteo, et al. e1002355 | 2011 | "Signatures of Environmental Genetic Adaptation Pinpoint Pathogens as the Main Selective Pressure through Human Evolution" | PLOS Genetics | ∅ | 7.11:: | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
- Comas, Iñaki, et al | 2013 | "Out-of-Africa Migration and Neolithic Coexpansion of Mycobacterium tuberculosis with Modern Humans" | Nature Genetics | ∅ | 45.10::1176–1182 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
- Quintana-Murci, Lluís; Andrew G | 2013 | "Population Genetic Tools for Dissecting Innate Immunity in Humans" | Nature Reviews Immunology | ∅ | 13.4::280–293 | Clark | ∅ | ∅ | ∅ | ∅ | ∅
- Hedrick, Philip W | 2011 | "Population Genetics of Malaria Resistance in Humans" | Heredity | ∅ | 107.4::283–304 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
- Sabeti, Pardis C., et al | 2002 | "Detecting Recent Positive Selection in the Human Genome from Haplotype Structure" | Nature | ∅ | 419.6909::832–837 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
- Karlsson, Elinor K., Dominic P | 2014 | "Natural Selection and Infectious Disease in Human Populations" | Nature Reviews Genetics | ∅ | 15.6::379–393 | Kwiatkowski, and Pardis C | ∅ | ∅ | ∅ | ∅ | Sabeti
- Luzzatto, Lucio. e2012065 | 2012 | "Sickle Cell Anaemia and Malaria" | Mediterranean Journal of Hematology and Infectious Diseases | ∅ | 4.1:: | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
- Spyrou, Maria A., et al | 2022 | "The Source of the Black Death in Fourteenth-Century Central Eurasia" | Nature | ∅ | 606.7915::718–724 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
CROSS-REFERENCE INDEX
| Related Doc | Connection |
|---|
| L_3_09 | HLA diversity |
| Z_4_13 | Infectious disease biology |
| X_1_01 | Epidemics and history |
| L72 | Ancient pathogen genomics |
Generated from V4 expansion plan. Last Updated: March 11, 2026
⚠️ AI-Assisted Research Disclaimer
This document was generated and structured with the assistance of AI tools.
While every effort is made to ensure accuracy, AI-assisted content may
contain errors, misattributions, or unintended inaccuracies. Always verify claims, dates, and sources independently before citing or relying
on any information presented here.
- Sources may contain errors. Bibliography entries and cross-references
are checked by automated systems, but mistakes can occur. If something
looks wrong, it may be.
- Speculative and unverified claims are clearly labeled. This project
uses a four-tier evidence system:
- Tier 1 — Verified: Peer-reviewed, established scientific consensus.
- Tier 2 — Credible: Academically supported, debated but grounded.
- Tier 3 — Speculative: Plausible but unverified by mainstream science.
- Tier 4 — Dubious: No credible support or contradicted by evidence.
- This project maps multiple perspectives — not a single truth. Mainstream,
alternative, and skeptical viewpoints are presented side by side for
critical comparison, not endorsement. Inclusion does not imply agreement.
- We are actively improving. Source verification, factuality scoring,
and bibliography enrichment are ongoing. Each revision adds stronger
citations, corrects identified errors, and expands coverage.
📖 For full details on our verification methodology, scoring systems, and
quality metrics, see: Fact-Checking & Verification Systems
Think Openly. Check the sources. Draw your own conclusions.